Cite

    Alifrangis, C., Wilson, P., & Shamash, J. (2018). letter to the Editor: Central nervous system relapse rate and dose intensification in poor risk metastatic germ cell tumours—A comment on: 'Patterns of relapse in poor prognosis germ cell tumours in the GETUG-13 trial: Implications for the assessment of brain metastases.' by Loriot and colleagues. European journal of cancer, 95, 102–103. http://access.bl.uk/ark:/81055/vdc_100060348930.0x00001f